Table 1.

Correlation between RAPTOR expression and clinicopathologic characteristics

Characteristics	No. of cases	RAPTOR expression		P valuea
		Low	High
Age (y)
≤60	22	5	17	.897
>60	79	19	60
Gender
Male	50	15	35	.145
Female	51	9	42
Pathologic subtype
Adenocarcinoma	63	14	49	.640
Mucinous adenocarcinoma	38	10	28
Pathological grading
pG1	23	5	18	.965
pG2	62	15	47
pG3	16	4	12
Lymph node status
N0	61	12	49	.340
N1	30	8	22
N2	10	4	6
Primary tumor
T1, T2	6	4	2	.0224*
T3	75	14	61
T4	20	6	14
TNM stage
I	6	1	5	.0143*
II	54	19	35
III‐IV	41	4	37

Abbreviation: RAPTOR, regulatory associated protein with mTOR.

^a χ ² test.

^*Significant correlation.